BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11060326)

  • 1. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis and antiangiogenic therapy.
    Sledge GW; Miller KD
    Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
    Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of angiogenesis in the brain].
    Mennel HD
    Strahlenther Onkol; 2000 Jan; 176(1):46-7. PubMed ID: 10650838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
    Plouet J
    Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor progression and angiogenesis].
    Maru Y
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1509-19. PubMed ID: 10500543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM
    Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy.
    Jones A; Harris AL
    Cancer J Sci Am; 1998; 4(4):209-17. PubMed ID: 9689977
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis update].
    Vandenbunder B
    Bull Cancer; 1999 Jan; 86(1):29-36. PubMed ID: 10029701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumor angiogenesis].
    Bussolino F
    Recenti Prog Med; 1999 Jan; 90(1):28-36. PubMed ID: 10193163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of endothelial cell networks.
    Helmlinger G; Endo M; Ferrara N; Hlatky L; Jain RK
    Nature; 2000 May; 405(6783):139-41. PubMed ID: 10821260
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
    Ellis LM
    J Clin Oncol; 2003 Dec; 21(23 Suppl):281s-283s. PubMed ID: 14645411
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.
    Guba M; von Breitenbuch P; Steinbauer M; Koehl G; Flegel S; Hornung M; Bruns CJ; Zuelke C; Farkas S; Anthuber M; Jauch KW; Geissler EK
    Nat Med; 2002 Feb; 8(2):128-35. PubMed ID: 11821896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.